Are you asking the right questions when treating #atopicdermatitis? Discover a proven approach to evaluating AD beyond the surface. Gain insights on enhancing your patients' quality of life, sleep, and overall well-being: https://lnkd.in/eVv-3Qgv #dermatology #dermatologist #healthcare #education #medicalresearch #medicalnews #skincare #eczema
ReachMD
Broadcast Media Production and Distribution
Fort Washington, Pennsylvania 2,862 followers
Be Part of the Knowledge.
About us
ReachMD is a multi-channel producer and distributor of education to healthcare professionals. In addition to offering over 10,000 programs and a personalized user experience, our digital platform includes on-demand content, live broadcasts, and 24/7 radio streaming. The ReachMD Distribution Network is accessible on websites and on the ReachMD, Amazon Alexa, iHeartRadio, TuneIn, iTunes, Stitcher, PlayerFM, and Google Play mobile apps, so that no matter where healthcare professionals are, they can always Be Part of the Knowledge.
- Website
-
http://www.ReachMD.com
External link for ReachMD
- Industry
- Broadcast Media Production and Distribution
- Company size
- 201-500 employees
- Headquarters
- Fort Washington, Pennsylvania
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Medical Communications, Continuing Medical Education, Healthcare Agency, Healthcare Communications, Medical News, CME Credits, and Specialty News
Locations
-
Primary
1301 Virginia Dr
Suite 300
Fort Washington, Pennsylvania 19034, US
Employees at ReachMD
Updates
-
Scalp psoriasis can significantly impact a patient’s life both physically and mentally. How can we achieve long-term control for these patients? Researchers conducted a post-hoc analysis of efficacy data on ixekizumab in moderate to severe, chronic plaque psoriasis and found promising results with this therapy over five years. The study shows significant, long-lasting reductions in itching, pain, and overall psoriasis severity, leading to better quality of life. These findings add to the growing body of evidence supporting the use of ixekizumab in achieving and maintaining long-term control of scalp psoriasis. Explore the full study and its clinical implications: https://ow.ly/LVEW50SG3mh #PlaquePsoriasis #ScalpPsoriasis #Dermatology #PsoriasisResearch #MedicalResearch
-
Alzheimer's disease impacts millions of Americans, and the numbers are only expected to rise in the following decades. Spotlight on Alzheimer’s Disease gathers the latest news and expert discussions on diagnostic and treatment advances. Equip yourself with expert knowledge and optimize patient care: https://ow.ly/bsG050SG3CP #AlzheimersDisease #Neurology #Neurologist #Healthcare #HealthcareProfessionals
This content isn’t available here
Access this content and more in the LinkedIn app
-
Despite advances in hepatocellular carcinoma care, significant barriers to diagnosis and treatment remain. In this in-depth review, we identify those barriers and outline key strategies for addressing them. Understand the impact of early detection, assess current methods of risk stratification, and explore promising avenues for advancing treatment. Dive into the review here: https://ow.ly/LuhL50SFc8b #HepatocellularCarcinoma #LiverCancer #Oncology #OncologyInsights #Healthcare
Hepatocellular Carcinoma: Reducing Barriers in Diagnosis and Treatment
reachmd.com
-
How early should we initiate long-acting injectable antipsychotics (LAIs) in the management of schizophrenia? For patients with schizophrenia, each relapse can lead to worsened symptoms, increased disability, and decreased treatment response. Tune in as Dr. Christoph Correll discusses the benefits of initiating long-acting injectable antipsychotics (LAIs) early in treatment to prevent relapses and hospitalizations. Discover insights from studies showing LAIs’ superior efficacy over oral treatments, their role in preventing emergency department visits, and strategies for proactive initiation. Enhance your practice with the latest insights on LAIs: https://ow.ly/Msbq50SFoIY #Schizophrenia #MentalHealth #LAIs #Psychiatry #EarlyIntervention
Too Soon Is Not Soon Enough: Initiation of LAIs Sooner to Manage Symptoms of Suboptimally Treated Schizophrenia
reachmd.com
-
Optimizing the Treatment Continuum With a Molecular-Based Approach in HER2+ GI Cancers
www.linkedin.com
-
TODAY is our LIVE broadcast on precision treatment strategies in HER2+ GI cancers. You don't want to miss these exclusive insights on molecular-based care. Join us: https://ow.ly/aqFr50StUY3 #ESMOGI24 #MedEd #CME #GICancer #PrecisionMedicine #Oncology
Optimizing the Treatment Continuum With a Molecular-Based Approach in HER2+ GI Cancers
reachmd.com
-
The alarming shortage of #ADHD medications is affecting millions of patients worldwide, posing significant challenges for those who rely on these treatments. Delve further into the implications of this shortage and explore potential solutions to provide patients the best care possible during this difficult time: https://ow.ly/mQNE50SFchp #MentalHealth #Mindfulness #MentalHealthMatters #ADHDMedication
This content isn’t available here
Access this content and more in the LinkedIn app
-
How does Duchenne muscular dystrophy (DMD) affect the emotional and social lives of patients and their families? New research sheds light on these challenges and highlights the critical role of family support. Delve into the findings from a recent study, which explores the frustrations of physical limitations, the emotional journey around the progressive nature of DMD, and the resilience fostered by strong support systems. Through interviews with patients and family caregivers, the study gives valuable insight into their perspectives on DMD’s impact on quality of life and the critical importance of family support. Dive further into the study with this recap: https://ow.ly/LK2U50SEsi9 #DuchenneMuscularDystrophy #Neurology #NeurologyInsights #MedicalResearch
Study Highlights Psychological, Social Challenges of Living with DMD
reachmd.com
-
What are the latest therapeutic options available for testosterone replacement therapy (TRT)? Join Drs. Mohit Khera and Omer Raheem as they explore the comprehensive landscape of current TRT modalities. They cover gels, oral medications, injectables, and insertable pellets, along with the newer nasal testosterone option. The discussion also highlights the importance of patient education, including strategies to ensure patients understand their condition and insights on personalizing TRT based on patient preferences and medical conditions. Enhance your knowledge and improve patient care by tuning in to this in-depth discussion: https://ow.ly/WNM250SEw8x #TRT #TestosteroneTherapy #Urology #Endocrinology #PatientCare #MedicalEducation #CliniciansRoundtable #EmergingTherapies #Hypogonadism #PatientEducation
Addressing Hypogonadism with Testosterone Replacement Therapies
reachmd.com